Home Infusion Therapy Market Size By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Industry Trends

Home Infusion Therapy Market size was USD 21 billion in 2019 and will witness a CAGR of 11% between 2020 and 2026. Home infusion therapy involves subcutaneous or intravenous administration of biologicals or drugs to a patient at their homecare. The market growth is attributed to cost efficiency and improved patient outcomes, along with rise in chronic diseases such as cancer, diabetes, asthma, obesity, and other life-threatening conditions. These medical conditions will impel the market growth over the forecast period.
 

Get more details on this report - Request Free Sample PDF

According to the World Health Organisation (WHO), chronic disease is a leading cause of deaths across the globe, accounting for 60% of mortality rate, thereby driving the requirements of different products of home infusion therapy for the treatment of these diseases. Hence, owing to these factors the home infusion therapy market will witness a significant growth in the coming period. The adoption of home infusion therapy products and services in developed and underdeveloped regions has increased due to cost-effective treatments in the past few years, thereby fostering the market growth positively.
 

Get more details on this report - Request Free Sample PDF
 

High preference of homecare facilities coupled with the rise in geriatric population will boost the adoption of home infusion therapy products and services globally

Rising preference for homecare facilities is anticipated to have positive impact on the demand for home infusion therapy services and products. Growing need to reduce the inpatient duration stays in hospitals is expected to propel the market growth thereby, enhancing the industry expansion. For instance, as per the American Hospital Association, in 2018, approximately 36 million hospital admissions were registered in the U.S. This has enforced to develop the strategies for the administration of home infusion therapy at homecare facilities and assisted in market expansion. Hence, owing to these factors home infusion therapy industry will witness a substantial growth over the years to come.
 

Immunocompromised patients, paediatrics and rising geriatric population coupled with various chronic diseases such as hospital-acquired infections and diabetes will further drive the market growth positively. Key market players are further focusing on the development of home infusion therapy devices by utilizing advanced technologies. However, risks associated with irregular functioning of infusion devices coupled with dearth of reimbursement policies for home infusion therapy may hamper the home infusion therapy market growth over the forecast period.
 

Increasing adoption of insulin pumps for rapid action will supplement market growth

Get more details on this report - Request Free Sample PDF
 

Infusion pump segment was valued at around USD 10.7 billion in 2019 and is estimated to hold significant market share during the forecast period. These pumps are extensively used in medical settings such as homecare, hospitals and nursing homes and thus significantly contribute to the medical devices market. Furthermore, infusion pumps offer several advantages including delivery of fluids at automated intervals or précised programmed rates and ability to deliver fluids in tiny volumes. Hence, owing to these advantages the market will witness a lucrative growth in the upcoming years. Infusion pumps are further widely used to deliver the fluids such as medication and nutrients.
 

Increasing demand for anti-infective therapy will create profitable opportunities, thereby boosting the market growth

Anti-infective segment held the highest market share in 2019 and is expected to expand at a CAGR of 10.8% during the forecast timeframe. High growth rate is due to the administration of medication such as anti-fungal and antibiotics that are performed in large number of procedures. This will generate significant demand for anti-infective therapy, thereby fuelling the market growth. The advantage of anti-infective treatment with home infusion therapy will led to cost-effective treatment by reducing in-patients stays in hospitals and exposure to the hospital-acquired infections. Thus, these advantages will contribute in the segmental growth, thereby increasing the adoption of home infusion therapy services.
 

Presence of major industry player in North America will surge the market growth

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America home infusion therapy market and was valued at around USD 8.4 billion in 2019. One of the key factors responsible for market growth across the U.S. is the presence of major industry players in the North America region. Increasing prevalence of chronic diseases will serve as a major impact rendering factor for the regional market size. Factors such as treatment cost, product launches and technological advancements are anticipated to upsurge the regional growth. Such factors will help in development of healthcare facilities, thereby augmenting the home infusion therapy product demand.
 

Growing shift towards the preference from acute care to homecare settings due to enhanced patient mobility and cost-effective treatment will foster the future market growth. For instance, National Home Infusion Association (NHIA) has resolved the affordability issues for geriatric population by implementing strategic initiatives to develop schemes for home infusion. Hence, such strategic decisions along with above mentioned factors will contribute significantly to boost the home infusion therapy industry growth in the coming years. Furthermore, owing to the advantages such as cost effectiveness and better clinical outcomes, the patients in the U.S. focus on administration of infusion therapy at home thereby, enhancing the market demand.
 

Implementation of various strategies is expected to create competitive advantages in the market growth

Some of the eminent players operating in the market include B. Braun Melsungen, Baxter, Fresenius Kabi, Becton, Dickinson & Company, Eli Lilly & Company, Smiths Medical, Terumo Corporation and ICU Medical, among others. These major industry players are focusing on various strategies such as R&D for new product launch, mergers & acquisitions to sustain market growth.
 

Recent industry developments:

• In April 2020, B Braun Melsungen received Emergency Use Authorization (EUA) from U.S. FDA for the use of infusion pump with nebulizers to treat COVID-19 patients. This has resulted in increased sales, expansion of customer base and market growth.
   
• In October 2018, Baxter International Inc. collaborated with the American Society for enteral and parenteral nutrition. The collaboration has led to launch of SmartPN tool that assist in reducing clinical malnutrition. This has increased the market demand and further assisted in industry growth.

The home infusion therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

By Product

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application

• Anti-infective
• Hydration Therapy
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Other

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil 
• Middle East & Africa
  • South Africa